Boothbay Fund Management’s ICU Medical ICUI Stock Holding History

Boothbay Fund Management’s Portfolio ICUI Stock Details ICUI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-10,000	Closed	-$1.82M	–	1689
2024 Q3	$1.82M	Buy	+10,000	New	+$1.48M	0.04%	549

Other funds holding ICUI

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Boothbay Fund Management's ICUI Position: Q4 2024 in Review

Boothbay Fund Management sold out of ICU Medical (ICUI) in Q4 2024, closing a stake of 12,536 shares — an estimated $2.28M sold.

Boothbay Fund Management first reported a position in ICUI in Q2 2022 and held it in 6 quarters. The position peaked at $2.71M in Q2 2024. 286 funds tracked by Wall St. Rank hold ICUI as of Q4 2024.

Boothbay Fund Management reported no remaining ICU Medical position as of Q4 2024 after selling out during the quarter.
Boothbay Fund Management sold 12,536 ICU Medical shares in Q4 2024, an estimated $2.28M.
Boothbay Fund Management first reported a position in ICU Medical in Q2 2022 and held it in 6 quarters.
Boothbay Fund Management's ICU Medical position peaked at $2.71M in Q2 2024.
286 funds tracked by Wall St. Rank held ICU Medical as of Q4 2024.

Based on Boothbay Fund Management's 13F filing for Q4 2024, filed 14 Feb 2025.